Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood

Coronavirus disease 2019 (COVID-19) vaccination in pregnancy induces a robust maternal immune response, with transplacental antibody transfer detectable in cord blood as early as 16 days after the first dose.

Saved in:
Bibliographic Details
Published inObstetrics and gynecology (New York. 1953) Vol. 138; no. 2; pp. 278 - 280
Main Authors Prabhu, Malavika, Murphy, Elisabeth A., Sukhu, Ashley C., Yee, Jim, Singh, Sunidhi, Eng, Dorothy, Zhao, Zhen, Riley, Laura E., Yang, Yawei J.
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 01.08.2021
Subjects
Antibody Formation
Contents
COVID-19
Female
Fetal Blood
Humans
Pregnancy
Pregnancy Complications, Infectious - prevention & control
Pregnant Women
Research Letter
RNA, Messenger
SARS-CoV-2
Vaccination
Online AccessGet full text

Cover

More Information
Summary:Coronavirus disease 2019 (COVID-19) vaccination in pregnancy induces a robust maternal immune response, with transplacental antibody transfer detectable in cord blood as early as 16 days after the first dose.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
ISSN:0029-7844
1873-233X
DOI:10.1097/AOG.0000000000004438